[1] Ioan P., Carosati E., Micucci M., Cruciani G., Broccatelli F., S Zhorov B., Chiarini A., Budriesi R.
1,4-Dihydropyridine Scaffold in Medicinal Chemistry, the Story so far and Perspectives (Part 1): Action in Ion Channels and GPCRs,
Curr. Med. Chem.,
18(32): 4901-22(2011).
[2] Carosati E., Ioan P., Micucci M., Broccatelli F., Cruciani G., Zhorov B., Chiarini A., Budriesi R.
1,4-Dihydropyridine Scaffold in Medicinal Chemistry, the Story so Far and Perspectives (Part 2): Action in other Targets and Antitargets,
Curr. Med. Chem.,
19(25): 4306-23(2012).
[3] Radadiya A., Khedkar V., Bavishi A., Vala H., Thakrar S., Bhavsar D., Shah A., Coutinho E.
Synthesis and 3D-QSAR Study of 1,4-Dihydropyridine Derivatives as MDR Cancer Reverters,
Eur. J. Med. Chem.,
74:375-87(2014).
[31] Chang C-C., Cao S., Kang S., Kai L., Tian X., Pandey P., Dunne SF., Luan C-H., Surmeier D.J., Silverman RB.
Antagonism of 4-Substituted 1, 4-Dihydropyridine-3, 5-Dicarboxylates Toward Voltage-Dependent L-Type Ca 2+ Channels Ca V 1.3 and Ca V 1.2,
Bioorg. Med. Chem.,
18(9): 3147-58(2010).
[33] Niaz H., Kashtoh H., Khan J.A., Khan A., Alam M.T., Khan K.M., Perveen S., Choudhary M.I.
Synthesis of Diethyl 4-Substituted-2,6-Dimethyl-1,4-Dihydropyridine-3,5-Dicarboxylates as a New Series of Inhibitors Against Yeast α-Glucosidase,
Eur. J. Med. Chem.,
95:199-209(2015).